Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ACH-000143
Cat. No.:
OB0425LY-120
Appearance:
Solid
Purity:
98.58%
Identity:
Confirmed by HPLC and LC-MS.
Size:
Add to basket
Product Overview
Description:
ACH-000143 is a potent and orally active melatonin receptor agonist with MT1 and MT2.
Synonyms:
2225836-30-4; N-[2-(5-Chloro-2,6-dimethoxy-1,3-benzodiazol-1-yl)ethyl]acetamide; N-(2-(5-Chloro-2,6-dimethoxy-1H-benzo[d]imidazol-1-yl)ethyl)acetamide
CAS No.:
2225836-30-4
Compound CID:
139451790
Formula:
C13H16ClN3O3
Formula Weight:
297.74
Specification
Target:
Melatonin receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
ACH-000143 can be used to develop new obesity drugs.
